Physician

Manisha Mittal, MD

According to 2025 Medicare claims, Manisha Mittal, MD (NPI: 1154627776) practices rheumatology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is VIVEK MITTAL, M.D. AND MANISHA MITTAL, M.D. INC. (NPI: 1194253872; TIN: 820847822) and primary practice location at 93720-0398.

Mittal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 248 traditional Medicare patients, billed 232,816 HCPCS/CPT codes, and received $4,462,291 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 343 prescription claims across 104 beneficiaries totaling $494,357 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 50 records totaling $1,164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,379 to $4,462,291. Similarly, Part D prescription costs have risen steadily, from $161,467 to $494,357. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	105	169	$12,379
2016	N/R	N/R	N/R
2017	80	969	$20,280
2018	200	14,190	$129,478
2019	239	23,754	$334,235
2020	269	73,902	$1,267,740
2021	277	123,548	$2,482,333
2022	364	182,637	$4,432,979
2023	281	188,791	$5,810,137
2024	248	232,816	$4,462,291

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	108	584	$161,467
2016	N/R	12	$1,680
2017	37	125	$14,498
2018	157	714	$131,502
2019	167	888	$188,771
2020	154	636	$264,085
2021	122	459	$226,778
2022	91	254	$275,038
2023	135	505	$706,800
2024	104	343	$494,357

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	26	26	$118
96413	Administration of chemotherapy into vein, 1 hour or less	80	500	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	194	508	$85
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	82	889	$55
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	48	158,400	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	34	952	$256,681
Humira(Cf) Pen	Adalimumab	11	364	$89,895
Enbrel	Etanercept	11	308	$80,662
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	71	5,312	$3,542
Mycophenolate Mofetil	Mycophenolate Mofetil	23	1,170	$1,961

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$1,164	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manisha Mittal, MD?

Tedicare shows public-source Medicare data for Manisha Mittal, MD (NPI 1154627776), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manisha Mittal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Manisha Mittal, MD?

Manisha Mittal, MD is linked to VIVEK MITTAL, M.D. AND MANISHA MITTAL, M.D. INC. (billing NPI 1194253872) in the available physician profile data.

Does Manisha Mittal, MD have Open Payments data?

Manisha Mittal, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.